The Sandiganbayan has acquitted former Food and Drug Administration chief Nela Charade Puno of graft, which stemmed from a ...

Received tentative approval from the FDA for YUTREPIA™ (treprostinil) inhalation powder for both pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung ...

pending FDA approval,” said Linda Marbán, Ph.D., Capricor’s chief executive officer. “In addition, we continue to advance our ...

They have,” says Katrine Wallace, Ph.D., epidemiologist and adjunct assistant professor ... Ku says that Kennedy could have ...

Serge Belanger’s rating is based on a clear path toward FDA approval and the subsequent launch of Yutrepia ... and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The recent ...

The Cebu Provincial Government has signed a memorandum of agreement with the Department of Science and Technology and the Food and Drugs Administration to improve the quality of products produced by ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Hello everyone, and welcome to the Mirum Pharmaceuticals’ Third ...

Q2 2024 Earnings Call Transcript November 12, 2024 Operator: Good day and thank you for standing by. Welcome to the Roivant ...

Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, ...

if approved; failure to compete successfully against other drug companies; protection of our proprietary technology and the confidentiality of our trade secrets; potential lawsuits for, or claims of, ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and Europe Completed ZYNQUISTA FDA Advisory Committee Meeting; PDUFA Goal Date December 20, 20 ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...